DaVita Inc. (NYSE:DVA) Shares Sold by Quadrature Capital Ltd

Quadrature Capital Ltd lowered its position in DaVita Inc. (NYSE:DVA - Free Report) by 76.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,047 shares of the company's stock after selling 6,767 shares during the quarter. Quadrature Capital Ltd's holdings in DaVita were worth $336,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. increased its stake in DaVita by 1.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,759 shares of the company's stock worth $776,000 after buying an additional 70 shares during the period. Wedmont Private Capital increased its stake in DaVita by 4.4% in the 3rd quarter. Wedmont Private Capital now owns 1,776 shares of the company's stock worth $280,000 after buying an additional 75 shares during the period. Blue Trust Inc. increased its stake in DaVita by 58.6% in the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company's stock worth $29,000 after buying an additional 78 shares during the period. First Trust Direct Indexing L.P. increased its stake in DaVita by 2.9% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 3,051 shares of the company's stock worth $500,000 after buying an additional 86 shares during the period. Finally, Nisa Investment Advisors LLC increased its stake in DaVita by 0.3% in the 3rd quarter. Nisa Investment Advisors LLC now owns 36,820 shares of the company's stock worth $6,036,000 after buying an additional 126 shares during the period. Hedge funds and other institutional investors own 90.12% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on DVA shares. Truist Financial raised their target price on shares of DaVita from $165.00 to $175.00 and gave the company a "hold" rating in a research report on Monday, October 7th. Barclays raised their target price on shares of DaVita from $150.00 to $164.00 and gave the company an "equal weight" rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $161.80.

DaVita Stock Down 2.6 %

Shares of NYSE:DVA traded down $4.07 during trading on Tuesday, reaching $153.99. The stock had a trading volume of 544,568 shares, compared to its average volume of 812,264. DaVita Inc. has a one year low of $103.40 and a one year high of $169.51. The company has a market capitalization of $12.63 billion, a P/E ratio of 17.05, a PEG ratio of 0.90 and a beta of 0.90. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. The firm's 50-day simple moving average is $158.46 and its 200 day simple moving average is $150.52.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts' consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The firm had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the prior year, the business posted $2.85 earnings per share. The firm's quarterly revenue was up 4.6% on a year-over-year basis. As a group, research analysts expect that DaVita Inc. will post 9.71 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $165.05, for a total value of $8,252,500.00. Following the completion of the sale, the chief executive officer now directly owns 837,835 shares in the company, valued at $138,284,666.75. This trade represents a 5.63 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.00% of the stock is owned by company insiders.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.